Heritable pulmonary arterial hypertension: new genetic findings and environmental triggers

Our goal was to identify new environmental or genetic causes in heritable pulmonary arterial hypertension (HPAH) families outside the 18 known diagnostics PAH genes. PAH gene panel sequencing was performed for 47 HPAH families which revealed pathogenic variants in 39 families. Five of the remaining...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shaukat, Memoona (Auteur) , Grünig, Ekkehard (Auteur) , Haas, Simon (Auteur) , Haas, Jan (Auteur) , Panahi, Mohammad (Auteur) , Granzow, Martin (Auteur) , Lange, Tobias J. (Auteur) , Stadler, Stefan (Auteur) , Sommer, Natascha (Auteur) , Dorfmüller, Peter (Auteur) , Meder, Benjamin (Auteur) , Harutyunova, Satenik (Auteur) , Egenlauf, Benjamin (Auteur) , Xanthouli, Panagiota (Auteur) , Hinderhofer, Katrin (Auteur) , Eichstaedt, Christina (Auteur)
Format: Article (Journal)
Langue:anglais
Publié: 2026
In: Scientific reports
Year: 2026, Volume: 16
ISSN:2045-2322
DOI:10.1038/s41598-025-34167-0
Accès en ligne:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41598-025-34167-0
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41598-025-34167-0
Accéder au texte intégral
Notes sur l'auteur:Memoona Shaukat, Ekkehard Grünig, Simon Haas, Jan Haas, Mohammad Panahi, Martin Granzow, Tobias J. Lange, Stefan Stadler, Natascha Sommer, Peter Dorfmüller, Benjamin Meder, Satenik Harutyunova, Benjamin Egenlauf, Panagiota Xanthouli, Katrin Hinderhofer & Christina A. Eichstaedt
Description
Résumé:Our goal was to identify new environmental or genetic causes in heritable pulmonary arterial hypertension (HPAH) families outside the 18 known diagnostics PAH genes. PAH gene panel sequencing was performed for 47 HPAH families which revealed pathogenic variants in 39 families. Five of the remaining families agreed to whole exome sequencing and to fill in a drug and toxin exposure questionnaire. In Family 1 and 2, mother and daughter with HPAH carried a likely pathogenic variant in the CYBA gene and a variant of uncertain significance in the FKBP1A gene, respectively, following ACMG guidelines. In Family 3, we detected a likely pathogenic variant in the PTGR2 gene. These genes could play part in PAH pathogenesis but further functional analyses are required to corroborate these findings. In the remaining two families, we could not identify any plausible genetic cause. However, a father and son with PAH reported exposure to trichloroethylene, asbestos and tramadol in Family 4. In Family 5, two brothers with pulmonary veno-occlusive disease showed occupational toxin exposure. Thus, our findings indicate that not only a genetic predisposition but also environmental triggers should be investigated for HPAH patients.
Description:Online veröffentlicht: 29. Januar 2026
Gesehen am 27.05.2026
Description matérielle:Online Resource
ISSN:2045-2322
DOI:10.1038/s41598-025-34167-0